CLOSE MENU
The Department of Epidemiology and Biostatistics forums are for students, staff, alumni, faculty, and other interested attendees to learn about recent research in the CUNY community, talk to representatives of the department, school, and related institutes, and meet each other in an online conference platform.
Keynote lecture:
Planning for implementation of novel HIV prevention for women
In the near future two new biomedical HIV prevention interventions could be available for use in women globally. Implementation science can play a key role in improving the public health impact of expanded Pre Exposure Prophylaxis.
Keynote Speaker: Dr. Delivette Castor, Assistant Professor of Epidemiology, Mailman School of Public Health, Columbia University
Dr. Delivette Castor is Assistant Professor (in Medicine and Epidemiology), Department of Medicine, Division of Infectious Diseases, and Department of Epidemiology, the Columbia University Medical Center. She is also Director of the section on Health Equity in Dissemination and Implementation Sciences in the Division of Infectious Diseases. Dr. Castor is an epidemiologist who studies how to introduce, and scale proven infectious disease interventions in public health programs for population-level impact within an equity framework. She has worked within multidisciplinary teams involving policymakers, program planners, and researchers to translate research to practice for voluntary medical male circumcision, PrEP, stigma, and gender-based violence interventions, among others.
Small talk:
Identifying disparities in HIV treatment: the confluence of activism and epidemiology
Globally, there are 28 million people living with HIV who are accessing lifesaving antiretroviral therapy. New regimens with the medication dolutegravir have the potential to improve HIV treatment outcomes on a massive scale. In my presentation, I will discuss how routine clinical data from the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium have provided an important opportunity to understand the global rollout of dolutegravir through a health equity lens.
Small talk speaker: Matthew Romo, Research Scientist, CUNY SPH
Matthew Romo is a pharmacist and epidemiologist interested in understanding how to equitably implement medications, vaccines, and other technologies to improve both patient and population health outcomes. He recently defended his PhD dissertation in epidemiology entitled “The Global Implementation of Dolutegravir for HIV Treatment” at the CUNY Graduate School of Public Health and Health Policy under the mentorship of Professor Denis Nash. He has taught epidemiology to students in New York City and Hong Kong, and has been involved in epidemiologic research both domestically and in Ecuador, Mexico, and Kenya. Matthew chose to pursue a career in public health while working for the pharmaceutical industry—and has not looked back.
